Summary
This article discusses current insights into spondyloarthropathies, including TNF inhibition, structural damage progression in ankylosing spondylitis, methotrexate as a disease-modifying agent, and reactive arthritis.
- inflammatory disorders
- © 2011 MD Conference Express